Literature DB >> 1924031

Crescentic transformation in primary membranous glomerulonephritis.

J T Kwan1, R H Moore, S M Dodd, J Cunningham.   

Abstract

A 31 year old man first developed steroid-resistant idiopathic membranous glomerulonephritis in 1981. Stable normal renal function was maintained until August 1988 when he suffered a clinical relapse with heavy proteinuria and declining renal function. Immunosuppressive therapy with prednisolone and cyclophosphamide was instituted in an attempt to arrest this relapse. Despite this, he later developed acute renal failure with histological evidence of crescentic transformation of his nephritis. This unusual transformation was not associated with features of systemic vasculitis or positive anti-glomerular basement membrane and anti-neutrophil cytoplasmic antibodies.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1924031      PMCID: PMC2398889          DOI: 10.1136/pgmj.67.788.574

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  12 in total

1.  Prednisolone and chlorambucil treatment in idiopathic membranous nephropathy with deteriorating renal function.

Authors:  P W Mathieson; A N Turner; C G Maidment; D J Evans; A J Rees
Journal:  Lancet       Date:  1988-10-15       Impact factor: 79.321

2.  An unusual variant of membranous nephropathy with abundant crescent formation and recurrence in the transplanted kidney.

Authors:  G S Hill; J Robertson; R Grossman; L Perloff; C F Barker
Journal:  Clin Nephrol       Date:  1978-09       Impact factor: 0.975

3.  Analysis of 260 cases of membranous glomerulonephritis in renal biopsy material.

Authors:  E Beregi; I Varga
Journal:  Clin Nephrol       Date:  1974 Nov-Dec       Impact factor: 0.975

4.  Evolution of membranous nephropathy into anti-glomerular-basement-membrane glomerulonephritis.

Authors:  J Klassen; C Elwood; A L Grossberg; F Milgrom; M Montes; M Sepulveda; G A Andres
Journal:  N Engl J Med       Date:  1974-06-13       Impact factor: 91.245

5.  Transformation of membranous glomerulonephritis into crescentic glomerulonephritis with glomerular basement membrane antibodies. Serial determinations of anti-GBM before the transformation.

Authors:  P Kurki; T Helve; M von Bonsdorff; T Törnroth; E Pettersson; H Riska; A Miettinen
Journal:  Nephron       Date:  1984       Impact factor: 2.847

6.  A controlled trial of cyclophosphamide in patients with membranous glomerulonephritis.

Authors:  M L West; K K Jindal; R A Bear; M B Goldstein
Journal:  Kidney Int       Date:  1987-10       Impact factor: 10.612

7.  Membranous glomerulonephropathy with crescents.

Authors:  G D Nicholson; U F Amin; G A Alleyne
Journal:  Clin Nephrol       Date:  1975-11       Impact factor: 0.975

8.  Idiopathic crescentic membranous glomerulonephritis.

Authors:  K Abreo; F Abreo; B Mitchell; G Schloemer
Journal:  Am J Kidney Dis       Date:  1986-10       Impact factor: 8.860

9.  Association of crescentic glomerulonephritis with membranous glomerulonephropathy: a report of three cases.

Authors:  A V Moorthy; S W Zimmerman; P M Burkholder; A R Harrington
Journal:  Clin Nephrol       Date:  1976-07       Impact factor: 0.975

10.  A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.

Authors:  C Ponticelli; P Zucchelli; P Passerini; L Cagnoli; B Cesana; C Pozzi; S Pasquali; E Imbasciati; C Grassi; B Redaelli
Journal:  N Engl J Med       Date:  1989-01-05       Impact factor: 91.245

View more
  6 in total

1.  Crescentic glomerulonephritis and membranous nephropathy: a rare coexistence.

Authors:  Olga Balafa; Rigas Kalaitzidis; Georgios Liapis; Sofia Xiromeriti; Fotios Zarzoulas; Georgios Baltatzis; Moses Elisaf
Journal:  Int Urol Nephrol       Date:  2015-06-20       Impact factor: 2.370

2.  Clinicopathological and long-term prognostic features of membranous nephropathy with crescents: a Japanese single-center experience.

Authors:  Masaya Saito; Atsushi Komatsuda; Ryuta Sato; Ayano Saito; Hajime Kaga; Fumito Abe; Masato Sawamura; Mizuho Nara; Masaru Togashi; Shin Okuyama; Hideki Wakui; Naoto Takahashi
Journal:  Clin Exp Nephrol       Date:  2017-08-29       Impact factor: 2.801

3.  Transformation of membranous into anti-GBM nephritis.

Authors:  S Imtiaz; A Alswaida; H Rehman; N Faraz; T Afshan; H Alkafoury; S Qayyum; M Al Khoiter
Journal:  Indian J Nephrol       Date:  2012-09

4.  Pauci Immune crescentic glomerulonephritis in a patient with T-cell lymphoma and argyria.

Authors:  Tamer Rezk; James Penton; Anna Stevenson; Mared Owen-Casey; Mark Little; John Cunningham; Alan D Salama
Journal:  BMC Nephrol       Date:  2016-05-17       Impact factor: 2.388

5.  Clinical Features and Outcomes in Patients With Membranous Nephropathy and Crescent Formation.

Authors:  Jia Wang; Ping Zhu; Zhao Cui; Zhen Qu; Yi-Miao Zhang; Fang Wang; Xin Wang; Jin-Wei Wang; Sai-Nan Zhu; Gang Liu; Fu-de Zhou; Ming-Hui Zhao
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

6.  Pauci-Immune Necrotizing and Crescentic Glomerulonephritis with Membranous Lupus Nephritis, Fifteen Years after Initial Diagnosis of Secondary Membranous Nephropathy.

Authors:  Ryan Burkhart; Nina Shah; Michael Abel; James D Oliver; Matthew Lewin
Journal:  Case Rep Nephrol       Date:  2015-10-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.